In order to determine if an adrenergic mechanism is involved in the secretion of corticotrophin (ACTH), the effect of adrenergic-blocking or -stimulating agent on plasma ACTH, cortisol and glucose levels was studied in normal human subjects. The 
ergic mechanism is involved in the regulation of growth hormone secretion and that either beta adrenergic blockade or alpha stimulation enhances growth hormone secretion, whereas either alpha blockade or beta stimulation sup¬ presses it.
However, controversial results were obtained concerning the role of cat¬ echolamines in regulating ACTH secretion. Krieger 8c Krieger (1970) reported that the implantation of norepinephrine into certain areas of the cat brain led to an acute rise in plasma corticosteroid levels. On the contrary, Ganong (1970) and Van Loon et al. (1971) observed an inhibitory effect of catechol¬ amines on ACTH secretion both in rats and dogs. Moreover, there is a report that brain amines played no important role in the control of ACTH secretion (De Schaepdryver et al. 1969) . All these studies were performed measuring plasma corticosteroids as a measure of ACTH release.
Since we have developed a sensitive radioimmunoassay of ACTH (Matsukura et (Murphy 1967) .
The following experiments were performed: 1) 25 mg of methoxamine, an alpha adrenergic-stimulating agent, dissolved in 500 ml saline was infused intravenously over a period of 2 h in 7 normal subjects. After this a combined administration of 25 mg methoxamine and 20 mg phentolamine, an alpha blocking agent, was performed in 5 of the 7 subjects who received methoxamine only.
2) The intravenous infusion of 10 mg or 15 mg of propranolol, a beta blocking agent, was performed in 4 and 4 subjects, respectively.
3) As a control experiment, 500 ml of saline solution was infused intravenously over a period of 2 h in 8 normal subjects. 4) Glucagon-free insulin (0.1 U/kg body weight) was injected intravenously im¬ mediately after the start of the intravenous infusion of 20 mg phentolamine, 10 mg propranolol or saline only. These 3 experiments were performed in the same 5 subjects at intervals of more than 1 week.
Statistical analysis was performed using Student's ¿-test, by comparing peak plasma ACTH or cortisol levels in saline control and experimental groups.
RESULTS
Effect of alpha adrenergic-stimulating agent on plasma ACTH, cortisol, and glucose
The plasma ACTH levels in normal man at 9.00 a. m. were 2 to 112 pg/ml, with a mean of 41.4 pg/ml. When only saline solution was infused as a control in 8 normal subjects, the plasma ACTH levels fluctuated moderately, but never exceeded 150 pg/ml during and following the infusion.
The intravenous infusion of an alpha adrenergic-stimulating agent, methox- Effect of concomitant administration of methoxamine and phentolamine on plasma ACTH and cortisol levels in 5 normal subjects. Plasma ACTH and cortisol responses to methoxamine were significantly blunted by the simultaneous administration of phentolamine (P < 0.01). Effect of intravenous infusion of propranolol on plasma ACTH and cortisol levels in 8 normal subjects. Intravenous infusion of propranolol caused no significant change in plasma ACTH and cortisol levels.
amine, caused a rise in plasma ACTH and cortisol during the infusion in 5 of 7 subjects as shown in Fig. 1 Fig. 2 . The peak plasma ACTH levels during the infusion of methoxaminephentolamine were significantly lower than those during the infusion of me¬ thoxamine only (P<0.01).
Effect of beta adrenergic-blocking agent on plasma ACTH, cortisol and glucose The intravenous infusion of 10 mg or 15 mg of propranolol, a beta adrenergicblocking agent, caused a slight rise in plasma ACTH in some subjects. However, the difference between peak ACTH and cortisol levels during propranolol infusion and those during saline infusion was not statistically significant (P>0.1) (Fig. 3) . Effect of alpha or beta adrenergic-blocking agent on plasma ACTH and cortisol responses to insulin-induced hypoglycaemia
The intravenous injection of glucagon-free insulin, 0.1 U/kg, produced a rise in plasma ACTH with peak values of 408.3 + 63.7 pg/ml (mean ± sem). In the same subjects, the plasma ACTH response to hypoglycaemia tested during the phentolamine infusion was partially but significantly inhibited as compared with the controls given saline only (P<0.01) (Fig. 4) .
On the other hand, beta adrenergic blockade with propranolol significantly enhanced the plasma ACTH response to insulin-induced hypoglycaemia as shown in Fig. 5 (?<0.01 ).
The mean minimal values of blood sugar induced by insulin during the in¬ fusion of phentolamine, propranolol and saline only were 47.5 + 1.5, 35.8 ± 2.3 and 40.8 ± 4.6 mg/dl, respectively. The differences between these values were not statistically significant. A rise in plasma ACTH and cortisol elicited by methoxamine may be ex¬ plained therefore either by its effect on the corticotrophin-secretory centres in the hypothalamus or by its peripheral action. However, the fact that phentol¬ amine, an alpha blocking agent, blunted a rise in plasma ACTH evoked by methoxamine or insulin-induced hypoglycaemia strongly suggests that the adrenergic mechanism is involved in ACTH secretion and that alpha receptors enhance it, as they also enhance HGH secretion (Imura et al. 1968 (Imura et al. , 1971 Blackard 8c Heidingsfelder 1968 
